CBD has become a multi-billion dollar business in short order, but solid evidence on product efficacy and safety is still in short supply, suggests a new paper from Mayo Clinic researchers
CBD has become a multi-billion dollar business in short order, but solid evidence on product efficacy and safety is still in short supply, suggests a new paper from Mayo Clinic researchers